India’s Bharat Biotech is gunning to produce 700 million doses of its COVID-19 shot Covaxin a year, and it’s won government cash and three new manufacturing partners help it reach that goal.
Sanofi and Regeneron’s Dupixent, also known as dupilumab, notched a win in a phase 3 study of patients with eosinophilic esophagitis (EoE), Sanofi said in…
Throughout the global push to produce COVID-19 vaccines, pharma companies have frequently come under fire for unequal access to their shots. Oxfam, in a bid…
A newly launched women’s telehealth and prescription delivery service founded by a longtime women’s magazine editor literally puts men in the hot seat while pondering…
A newly launched women’s telehealth and prescription delivery service founded by a longtime women’s magazine editor literally puts men in the hot seat while pondering…
More than a decade after its founding, Agios Pharmaceuticals has its first FDA green light. With the approval for Pyrukynd to treat hemolytic anemia in…
The U.S. approval of the first new Alzheimer’s disease drug in nearly two decades caused a major boon in research, but, for marketers, the fallout…
While crosstown rivals Roche and Novartis routinely rank among the world’s top five drugmakers by revenue, their CEOs typically fall outside the ranks of the…
While many people are suffering from Zoom fatigue and looking forward to in-person meetups, that isn’t really the case when it comes to HCPs and…
The future of cancer drug marketing will be about helping oncologists understand the complexities of precision medicine and how new advances in targeted therapies can…
For years, federal prosecutors have gone after drug companies for allegedly using charity contributions as a way to boost sales. Biogen was among the pharma players to ink a federal settlement, but, now, insurance…
